Lithospermoside

Overview

Lithospermoside (Griffonin) is an orally active Na + /K + -ATPase inhibitor and hypoglycemic agent. Lithospermoside increases intracellular sodium levels in normal and sickle red blood cells. Lithospermoside reduces fasting blood glucose levels, improves glucose tolerance, and prevents weight loss in diabetic mice. Lithospermoside can be used in the research of sickle cell disease and diabetes.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Blood Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Sickle Cell Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Na+/K+ ATPase

Product Information

• Catalog No.: HY-N0821
• CAS No.: 63492-69-3
• Molecular Formula: C14H19NO8
• Molecular Weight: 329.30
• Purity: 99.48%
• Storage: -20°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source